EPIRUS Biopharmaceuticals, Inc./ US29428P1075 /
06/02/2024 20:34:32 | Diferencia - | Volumen | Bid- | Ask- | Máximo del día | Price Change Band |
---|---|---|---|---|---|---|
0.0000USD | - | 500 Volumen de negocios: .0005 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 0.0000 | 0.0000 |
GlobeNewswire
18:08
DEADLINE ALERT for GDRX, CORBF, LNC, and ADSK: The Law Offices of Frank R. Cruz Reminds Investors of...
GlobeNewswire
18:05
Swift Navigation Runs Its ISO 26262 Certified Skylark Precise Positioning Service on AWS
GlobeNewswire
18:00
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with ...
GlobeNewswire
18:00
Yurts and Carahsoft Partner to Bring Comprehensive Generative AI Platform to the Public Sector
GlobeNewswire
17:55
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before...
GlobeNewswire
17:51
RAPID + TCT to Tackle the Industrialization of Additive Manufacturing in First Session of Inaugural ...
GlobeNewswire
17:50
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Rivian Automotive, Inc. with ...
GlobeNewswire
17:42
Evidency unveils a new era of trust in digital and sets new compliance standards for enterprises and...
GlobeNewswire
17:37
ASSETMARK INVESTOR ALERT: Public Equity Buyout May Be Unfair To Shareholders; Block & Leviton Urges ...
GlobeNewswire
17:33
Dr. María José Torres, Head of the Allergology Department of the HRU of Malaga, new President of the...
GlobeNewswire
17:27
Edgesource Windtalker™ Counter sUAS Enhances Situational Awareness During U.S. Army 25th Infantry Di...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página